ARTICLE | Company News
Affymetrix, Medical Prognosis Institute A/S deal
October 6, 2008 7:00 AM UTC
Affymetrix granted Medical Prognosis a non-exclusive license to Affymetrix's microarray technology to develop and commercialize tests to predict sensitivity to drugs and prognostic tests for cancer. ...